Clinical Trial Update: Assessing the Efficacy and Tolerability of AZARGA® (Brinzolamide 1%/Timolol 0.5% Fixed Combination) as Replacement Therapy in Patients on COMBIGAN® (Brimonidine 0.2%/Timolol 0.5% Fixed Combination) Therapy in Brazil [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating AZARGA (brinzolamide 1%/timolol 0.5%) as a replacement therapy for COMBIGAN in glaucoma patients was terminated in Brazil; results we…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma

Drugs mentioned

• Azarga (brinzolamide; timolol maleate)
• Combigan (brimonidine tartrate and timolol maleate)

Snippet

Sponsor: Alcon Research | Conditions: Glaucoma | Phase 4 | Status: TERMINATED | Results posted: 2013-10-21